GlaxoSmithKline | GSK - Lucro Bruto Sobre Vendas

Preço das Ações
1,918.00
Mudança Diária
-110.00 -5.42%
Mensal
-7.03%
Anual
29.29%
Q2 Previsão
1,986.06




Lucro Bruto Sobre Vendas Alterar Data
AbbVie USD 12.07B 1.59B 2025-12
Alcon AG USD 1.52B 58M 2025-12
Almirall EUR 429.87M 180.02M 2025-12
Amgen USD 6.48B 307M 2025-09
argenx SE USD 1.14B 118.49M 2025-12
AstraZeneca USD 12.39B 5M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Biogen USD 1.65B 34.6M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Eli Lilly USD 14.59B 1.48B 2025-09
Fresenius EUR 1.51B 214M 2025-12
Fresenius Medical Care EUR 1.39B 147M 2025-12
Galapagos EUR -13.57M 74.82M 2025-09
Genmab DKK 977M 13M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Glaxosmithkline GBP 8.75B 2.92B 2025-09
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lonza CHF 1.29B 248M 2025-06
Merck EUR 2.96B 252M 2025-12
Merck USD 13.42B 431M 2025-09
Novartis USD 10.25B 570M 2025-12
Novo Nordisk DKK 64.01B 1.19B 2025-06
Orion EUR 254M 254.7M 2026-03
Pfizer USD 3.54B 7.61B 2025-09
Philips EUR 2.29B 377M 2025-12
Recordati EUR 432.41M 8.56M 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
UCB EUR 3.19B 621M 2025-12